BRAIN Biotech Balance Sheet Health
Financial Health criteria checks 5/6
BRAIN Biotech has a total shareholder equity of €17.6M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €74.1M and €56.6M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €12.97m |
| Equity | €17.56m |
| Total liabilities | €56.59m |
| Total assets | €74.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0RFI's short term assets (€30.6M) exceed its short term liabilities (€11.9M).
Long Term Liabilities: 0RFI's short term assets (€30.6M) do not cover its long term liabilities (€44.7M).
Debt to Equity History and Analysis
Debt Level: 0RFI is debt free.
Reducing Debt: 0RFI had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0RFI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0RFI has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 5.5% each year